Diversity-generating retroelements (DGRs) mediate accelerated evolution in thousands of microorganisms and are evolutionarily related to diverse retroelements that include group II introns, retrons, reverse transcriptase (RT)-encoding CRISPRs, non-long terminal repeat (non-LTR) retrotransposons, and retroviruses ([@r1][@r2][@r3]--[@r4]). The prototypical DGR was discovered in *Bordetella* bacteriophage BPP-1, where it facilitates phage tropism switching by diversifying a gene (*mtd*) encoding its receptor recognition function ([@r5]). DNA sequence hypervariation occurs through mutagenic homing, a unidirectional transposition process from a template repeat (*TR*) to a variable repeat (*VR*) with concomitant *VR* mutations corresponding to *TR* adenine residues ([@r1], [@r5]) ([Fig. 1*A*](#fig01){ref-type="fig"} and [Fig. S1](#d35e326){ref-type="supplementary-material"}). Homing requires a *TR* RNA intermediate and two DGR-encoded proteins, Avd (accessory variability determinant) and bRT (*Bordetella* reverse transcriptase) ([@r1], [@r5][@r6]--[@r7]). It has been hypothesized that homing occurs through a target-primed reverse transcription mechanism, similar to the mobility mechanisms of related retroelements ([@r8][@r9][@r10]--[@r11]); however, this model deserves further scrutiny. The directionality of BPP-1 DGR homing is controlled by its target (*VR*) recognition requirements, which include a (GC)~14~ element, a 21-bp initiation of mutagenic homing (IMH) sequence, and a DNA stem--loop structure at the 3′ end ([@r1], [@r2], [@r6], [@r12]) ([Fig. 1 *A* and *B*](#fig01){ref-type="fig"}). Target recognition at the 5′ end of *VR* is determined by homology with *TR*, but is otherwise sequence-independent ([@r6]). Guided by these rules, the BPP-1 DGR was engineered to retarget a heterologous gene encoding kanamycin resistance ([@r12]).

![Target-independent cDNA synthesis of the BPP-1 DGR. (*A*) BPP-1 DGR mutagenic homing and phage tropism switching. The BPP-1 DGR consists of three genes (*mtd*, *avd*, and *brt*) and two repeats, *TR* and *VR*. *VR* is located at the 3′ end of *mtd*, which encodes a receptor-recognizing tail fiber protein. IMH and IMH\* are located at the 3′ ends of *VR* and *TR*, respectively, downstream of a 14-bp GC-rich element. Downstream of *VR* is a stem--loop DNA structure. Phage tropism switching results from DGR mutagenic homing (MH), which is a *TR*-to-*VR* transposition that results in *VR* mutations corresponding to *TR* adenine residues. Mutagenic homing occurs through RNA and cDNA intermediates, with A-mutagenesis proposed to occur during reverse transcription, either through direct misincorporation of random nucleotides (**N**) or via dUTP incorporation (not shown). The mechanism of cDNA priming and the step at which A-mutagenesis occurs are determined in this study. (*B*) Requirements of BPP-1 DGR target recognition. (*C*) Strategy of cDNA detection. Plasmid pMX-*td* expresses Avd, bRT, and *TR*, which is *td* intron (red)-tagged, from the *fhaB* promoter (P*fha*). After transcription and intron splicing, only ligated exons (green) will be retained in *TR* RNA (blue). If cDNA synthesis occurs, the products (pink) can be detected by PCR with primers P1 and E2a. ?, unknown cDNA priming sequence. (*D*) cDNA products (\*) are detected in pMX-*td*-transformed *Bordetella* cells by PCR. The 148-bp band was not detected in mutants that are RT-deficient (SMAA), splicing defective (∆P7.1--2a), or with an inverted intron (*td*-). Positive control pMX-E1E2 contains ligated exons in *TR*. The ∼500-bp band is the PCR products amplified from the *td* intron-containing *TR* DNA in the plasmids (pMX-*td*, pMX-*td*/SMAA, pMX-*td*/ΔP7.1-2a or pMX-*td*Δ*avd*). The primers used for PCR were P1, which is a sense-strand primer annealing to the 5\' end of *TR*, and E2a, which is an antisense-strand primer annealing to *td* exon 2. (*E*) Avd is essential for cDNA synthesis. Δ*avd*, an *avd* deletion mutant.](pnas.1715952114fig01){#fig01}

Adenine-specific mutagenesis (A-mutagenesis) is a hallmark of DGR activity. As *RT* is the only protein-encoding gene found in all DGRs, DGR RTs have been predicted to be responsible for A-mutagenesis ([@r2]). Consistent with this, adenines are found to be unaltered in the *TR* RNA intermediate, and A-mutagenesis has been proposed to result from random nucleotide incorporation when DGR RTs reverse transcribe *TR* adenine residues ([@r2], [@r6]). However, an alternative hypothesis, which involves adenine-templated dUTP incorporation by the DGR RT, was also proposed ([@r2], [@r6]). Accordingly, uracil bases would be subsequently removed by uracil DNA glycosylase (UDG) and random nucleotides inserted when DNA polymerases copy abasic sites.

Here, we determined the mechanism of DGR mutagenic homing. By tagging *TR* with a self-splicing group I intron, we found that cDNA synthesis occurs in the absence of *VR* target sequences. 5′ RACE (rapid amplification of cDNA ends) and mutagenesis studies showed that reverse transcription of *TR* RNA is primed by an adenine residue at position 56 downstream of *TR*. Remarkably, we found that the catalytic center of bRT is essential for site-specific cleavage of *TR* RNA at A56 for cDNA initiation. A-mutagenesis occurs during minus-strand cDNA synthesis and does not require adenine-templated polymerization of dU residues, indicating that A-mutagenesis is likely caused by bRT-mediated random nucleotide addition. Most importantly, we observed a strong correlation between the effects of different mutations on cDNA synthesis and their effects on mutagenic homing, suggesting the BPP-1 DGR functions through a target-independent reverse transcription mechanism.

Results {#s1}
=======

*VR*-Independent cDNA Synthesis. {#s2}
--------------------------------

As an initial test of the target-primed reverse transcription model for DGR homing, we determined whether cDNA synthesis can occur in the absence of *VR* target sequences. *Bordetella bronchiseptica* RB50, which contains no BPP-1 sequences, was transformed with pMX-*td*, which expresses DGR components Avd, bRT, and *TR* RNA tagged with a self-splicing *td* intron, under transcriptional control by an inducible *fhaB* promoter (P*fha*) ([@r6]) ([Fig. 1*C*](#fig01){ref-type="fig"}). After transcription and intron splicing, the mature *TR* RNA retains a 36-nt ligated exon sequence (E1E2). Plasmid pMX-E1E2 is a positive control that contains the same ligated exons. Induced cells were used as templates for PCR analysis, using primers P1 and E2a. P1 is a sense-strand primer annealing to the 5′ end of *TR*, and E2a is an antisense-strand primer annealing to *td* exon 2 ([Fig. 1*C*](#fig01){ref-type="fig"}). In addition to a larger band (541 bp) amplified from the intron-containing *TR* of pMX-*td*, we observed a smaller band (148 bp) that has the same size as products generated from pMX-E1E2 ([Fig. 1*D*](#fig01){ref-type="fig"}). The smaller band was not detected in the RT-deficient mutant (pMX-*td*/SMAA), which contains the YMDD to SMAA mutation in the bRT catalytic center, nor in the *avd* deletion mutant, or mutants that have a defective (∆P7.1--2a) or inverted (*td*-) intron ([Fig. 1 *D* and *E*](#fig01){ref-type="fig"}). Together, these results showed that *VR*-independent reverse transcription had occurred in vivo and required both bRT and Avd, and that spliced products of the *TR* RNA intermediate had been used as templates. A-mutagenesis was detected in the smaller products derived from pMX-*td* (frequency = ∼39.8%), demonstrating that A-mutagenesis occurs in a step before cDNA integration into *VR*, most likely as a result of error-prone nucleotide incorporation by bRT ([Fig. S2](#d35e326){ref-type="supplementary-material"}).

cDNA Priming by *TR* RNA. {#s3}
-------------------------

A 5′ RACE assay was next performed to identify the primer used for *VR*-independent cDNA synthesis. Total nucleic acids were isolated from RB50 cells transformed with pMX-*td* after P*fha* induction. A 5′ biotin-labeled sense-strand *td* exon oligo (EJBio) was annealed to (−)cDNA for primer extension in the presence of SuperScript III RT ([Fig. 2*A*](#fig02){ref-type="fig"}). The resulting biotinylated products were purified using streptavidin magnetic beads, and subsequently poly(dA) tails were added to the 3′ ends of these cDNA products using terminal deoxynucleotidyl transferase (TdT). The products were amplified using nested PCR, first with primers EJ+9 (*td* exon junction primer with 9 nt from E2) and dT18 \[annealing to the poly(dA) tail\], and then with primers EJ+16 (containing 16 nt from E2) and dT18. We detected a ∼170-bp band for pMX-*td* and a significantly weaker band for the SMAA mutant, which was also of slower mobility ([Fig. 2*B*](#fig02){ref-type="fig"}). Both products were cloned and sequenced. In all clones derived from pMX-*td*, we found that the *TR*-derived sequence was selectively mutated at adenine residues and fused to a sequence from the spacer (*sp*) region between *TR* and *brt*, but in the reverse orientation, suggesting this sequence had folded back onto *TR* to initiate cDNA synthesis ([Fig. 2 *C* and *D*](#fig02){ref-type="fig"}). Because of complementarities between *TR*U118 (uracil at *TR* position 118) and *sp*A56 (adenine at *sp* position 56), and between *TR*G119 and *sp*C55, it was not clear whether *sp*U54, *sp*C55, or *sp*A56 was the priming nucleotide. The four SMAA-derived clones analyzed contain *TR* (1/4) or both *TR* and *sp* (3/4) sequences, and none have A-mutagenesis in the *TR* region, suggesting they were not derived from bRT synthesized cDNA ([Fig. S3](#d35e326){ref-type="supplementary-material"}).

![cDNA synthesis is primed by a sequence between *TR* and *brt*. (*A*) Schematics of the 5′ RACE assay. EJBio, a biotin-labeled primer annealing to the *td* exon junction, was used as a primer to copy the (−)cDNA and the endogenous primer, using SuperScript III RT. The products were purified with streptavidin magnetic beads, tailed with poly(dA), using TdT, and amplified by nested PCR. The products were cloned into pSK II(+) plasmid for sequencing. Primers EJ+9, EJ+16, and dT18 are also indicated. Green bars represent *td* exons 1 and 2. Pink represents (−)cDNA. Black arrows and lines represent primers and other DNAs. (*B*) 5′ RACE products generated from pMX-*td* and pMX-*td*/SMAA derived nucleic acids. (*C*) Alignment of the sequences derived from the 5′ RACE assay of pMX-*td*. *TR*-derived sequences are marked with a pink line. Primer-derived sequences are marked with a black line and ???. The overlapping region could be derived from either the primer or the template. The annealing sites of primers EJ+16 and dT18 are also indicated. (*D*) cDNA synthesis is primed by a spacer (*sp*) sequence between *TR* and *brt*. The *sp* sequence folds back to prime cDNA (pink) synthesis of *TR* (blue). The priming residue could be *sp*U54, *sp*C55, or *sp*A56. Black lines, RNA sequences upstream and downstream of *TR*. Residues *TR*118 and *sp*56 are labeled.](pnas.1715952114fig02){#fig02}

To determine the exact cDNA initiation site, we introduced targeted mutations into plasmid pMX-*td* and determined their effects on cDNA synthesis. Two substitutions (*sp*C55U and *sp*A56G) were introduced into the primer region, and the other two (*TR*U118C and *TR*G119A) change complementary nucleotides on the template side (residues were named according to the *TR* RNA sequence; U = T; [Fig. 3*A*](#fig03){ref-type="fig"}). Nucleic acids were isolated from transformed RB50 cells. Covalently linked RNA-cDNA molecules were reverse transcribed with primer EJ+2 (containing 2 nt from E2), and products were amplified by PCR, using primers EJ+10 (containing 10 nt from E2) and TRsp, which anneals to the *TR*-*sp* junction ([Fig. 3*B*](#fig03){ref-type="fig"}). All mutations affected *VR*-independent cDNA synthesis. Three mutants, *TR*U118C, *TR*G119A, and *sp*C55U, remained functional and generated A-mutagenized cDNA products, whereas *sp*A56G had no detectable cDNA synthesis ([Fig. 3 *C* and *D*](#fig03){ref-type="fig"}). In agreement, mutant *sp*M4, which has a 5′-^55^CAGC to 5′-^55^GUCG mutation, had no detectable cDNA synthesis ([Fig. 3 *A* and *C*](#fig03){ref-type="fig"}). Sequence analysis also yielded information on cDNA initiation ([Fig. 3*E*](#fig03){ref-type="fig"}). Mutations *TR*U118C and *TR*G119A were not copied into cDNA products, whereas *sp*C55U was detected at the primer--cDNA junction, suggesting *sp*A56 was the priming residue and *TR*G117 was the first nucleotide being reverse transcribed. Complementary mutations *TR*U118C-*sp*A56G and *TR*G119A-*sp*C55U partially rescued defects in cDNA synthesis resulting from corresponding single-base mutations ([Fig. 3*D*](#fig03){ref-type="fig"}). Sequence analysis detected mutations *sp*A56G and *sp*C55U at the primer--cDNA junction ([Fig. 3*F*](#fig03){ref-type="fig"}). As mutations *TR*U118C and *TR*G119A alone were not copied into cDNA products, this observation again indicated that *sp*56 is the priming site and that a guanine substitution can be tolerated if paired with a cytosine at *TR*118. Interestingly, sequence analysis of cDNA products also showed nontemplated nucleotide addition in mutants *TR*U118C, *TR*G119A, and *sp*C55U, but not in the complementary mutants ([Fig. 3 *E* and *F*](#fig03){ref-type="fig"}). Bases were inserted between position *sp*A56 and the nucleotide copied from *TR*G117 and ranged from 2 to 7 nt, with no obvious pattern observed. It appears that primer--template mispairing induces nontemplated polymerization during cDNA initiation.

![The priming residue and effects of *TR* RNA mutations on cDNA synthesis. (*A*) Diagram to show introduced mutations in *TR* and *sp* sequences. (*B*) Diagram to show primers used for RT-PCR assay. Primers EJ+2 and EJ+10 are *td* exon junction oligos with 2 and 10 nt of E2, respectively. TRsp anneals to the junction of *TR* and *sp*. (*C* and *D*) RT-PCR assays to analyze cDNA synthesis in single and complementary mutants. (*C, Left*) Results of 25 PCR cycles. (*C, Right*) Results of 30 cycles for samples 2, 3, 6, and 7. Only products from reactions 1, 3, 4, and 5 showed A-mutagenesis. (*D*) 27 cycles. \*Expected products. (*E*) Sequences at the junction of the RNA primer and cDNAs of the three functional single-base mutants. The sense-strand sequence was aligned. Sequences to the left and right of the vertical lines were derived from cDNA and the primer, respectively. Open and filled arrows show absence and presence of the introduced mutations in the RT-PCR products, respectively. Nontemplated polymerization was observed between the priming residue and the nucleotide copied from *TR*G117 in some products. (*F*) Sequences at the junction of the RNA primer and cDNAs of complementary mutants *TR*G119A-*sp*C55U and *TR*U118C-*sp*A56G.](pnas.1715952114fig03){#fig03}

*TR* RNA Is Cleaved at the Priming Site. {#s4}
----------------------------------------

To determine whether *TR* RNA is cleaved at *sp*A56 during homing, we performed an RNase protection assay with a ^32^P-labeled antisense RNA probe that is complementary to *TR* RNA from position *sp*5 to position 6 of *brt* ([Fig. 4*A*](#fig04){ref-type="fig"}). We compared RNase protection patterns of RNA samples isolated from RB50 harboring plasmid pMX-Km1 or its RT-deficient mutant SMAA ([@r12]). An additional mutant, pMX-Km1/*sp*M4, was used as a positive control, as it contains the 5′-^55^CAGC to 5′-^55^GUCG mutation in the priming region. This results in mispairing between *TR* RNA and the labeled probe, thus allowing RNase cleavage ([Fig. 4*A*](#fig04){ref-type="fig"}). Indeed, we detected two protected bands in *sp*M4, which were ∼52 and ∼94 nt, respectively, corresponding to 5′ and 3′ cleavage products ([Fig. 4*A*](#fig04){ref-type="fig"}). Interestingly, we observed two similar products in the wild-type construct, but not in the SMAA mutant, predicating the hypothesis that the *TR* RNA template was cleaved in a bRT-dependent manner to generate a 3′-OH primer for cDNA synthesis. An alternative possibility, however, is that cDNA synthesis is initiated at the 2′-OH of *sp*A56, resulting in a branched structure that impairs base pairing of the probe with *TR* RNA and allows RNase cleavage. Interestingly, deletion of either *avd* or *brt* reduced *TR* RNA levels in vivo, suggesting that Avd and bRT, which are known to interact, bind the *TR* RNA substrate and protect it from degradation ([@r7]) ([Fig. 4*A*](#fig04){ref-type="fig"}).

![bRT-dependent *TR* RNA cleavage at the cDNA priming site. (*A*, *Left*) Diagram of the RNase protection assay. *TR*, blue; *sp*, black; cDNA, pink; uniformly labeled antisense RNA probe, red. Arrowheads indicate RNase cleavage sites (*Right*). *sp*M4, which has four mutated residues at the priming area, served as a positive control. The two protected fragments are indicated by green and red triangles. Km1 and SMAA are wild-type and catalytically inactive bRT constructs, respectively. (*A*, *Right*) RNase protection analysis. The 194-nt band is probe, the 146-nt band is probe cleaved by RNase at the unpaired ends, and the 94- and 52-nt bands are RNase protection products resulting from cleavage at the priming region and the two ends. Δ*avd* and Δ*brt* are deletion mutants of *avd* and *brt*, respectively. (*B*) Primer extension assay of wild type (Km1) and bRT-deficient mutants (SMAA, YMDA, YMAD and YMAA) with a ^32^P-labeled primer (P2) annealing downstream of *sp*A56. Two bRT-dependent bands (*sp*A56 and *sp*G57) are observed, suggesting that *TR* RNA is either cleaved or branched at *sp*A56. Sequencing ladders were generated from pMX-Km1 with the same labeled primer. Shown below is a diagram of *TR* RNA cleavage at *sp*A56. (*C*) Primer extension assay of Km1 and the SMAA mutant with a ^32^P-labeled primer (P3) annealing to (−)cDNA. Km1-specific terminations were detected in the IMH\* region (blue dot) after passing the cDNA-RNA primer junction (red dot). The junction did not block primer extension. Sequencing ladders were generated from pMX-Km1 with the same labeled primer. (*D*) Primer extension of splint ligation products with ^32^P-labeled primer P2. Ligation of adaptor DNA oligos to *sp*G57 of cleaved *sp*RNA occurred in the presence of a Bridge DNA oligo (3′ biotin-tagged) and T4 DNA ligase. 16-mer, 18-mer, and 20-mer are 16-nt, 18-nt, and 20-nt adaptors. Oligo 2nt-gap is 2 nt away from *sp*G57 after annealing. −, a negative control with no adaptor oligo added. Sequencing ladders were generated as in *B*. Primer extension products generated from those of splint ligation are marked by green dots. The ligation product of the 20-mer adaptor could not be detected because of a comigrating background band.](pnas.1715952114fig04){#fig04}

We reasoned that if *TR* RNA cleavage had occurred, it should be possible to map the cleavage site by primer extension ([Fig. 4*B*](#fig04){ref-type="fig"}). Using a ^32^P-labeled primer annealing downstream of *sp*A56, two products that correspond to termination at positions *sp*G57 or *sp*A56 were detected in the wild-type construct, but not in mutants containing substitutions in the YMDD box of the bRT catalytic center (SMAA, YMDA, YMAD, or YMAA). A likely explanation is that the *TR* RNA intermediate was cleaved between *sp*G57 and *sp*A56, with the slower-migrating band resulting from nontemplated nucleotide addition by SuperScript III RT ([@r13]) ([Fig. 4*B*](#fig04){ref-type="fig"}). Using a primer annealing to (−)cDNA ([Fig. 4*C*](#fig04){ref-type="fig"}), multiple bRT-dependent terminations were observed within the IMH\* region of *TR* RNA, matching the major region of poly(dA) addition in the 5′ RACE assay ([Fig. 2*C*](#fig02){ref-type="fig"}). In contrast, we did not observe bRT-dependent termination at the RNA-cDNA junction, which would be expected if there were a branched intermediate resulting from cDNA priming by the 2′-OH of *sp*A56 ([@r14][@r15]--[@r16]).

To further test the *TR* RNA cleavage hypothesis, we performed a splint ligation reaction followed by primer extension to detect free 5′-phosphoryl groups on *sp*G57, the predicted products of cleavage at *sp*A56 ([Fig. 4*D*](#fig04){ref-type="fig"}). Nucleic acids isolated from *Bordetella* cultures were combined with adaptor DNA oligos of different lengths and a bridge oligo that base pairs with adaptors and *sp*RNA from *sp*G57 to *sp*U74. After annealing, 16-mer and 18-mer adaptor oligos, which place 3′-OH groups directly adjacent to *sp*G57, were ligated by T4 DNA ligase, and reaction products of expected sizes were detected by primer extension ([Fig. 4*D*](#fig04){ref-type="fig"}). A 20-mer adaptor with the same 3′ terminus was also expected to serve as a ligation partner, but the predicted product was obscured by a background band. Oligo 2nt-gap, which anneals 2 nt away from *sp*G57, failed to generate ligation products, as expected. Most important, the ability to detect splint ligation products required enzymatically active bRT. Together, these observations support a model in which *TR* RNA is cleaved at *sp*A56 in a bRT-dependent manner, leaving a 5′ phosphate on *sp*G57 and a 3′-OH on *sp*A56 to initiate cDNA synthesis.

Mutagenic Synthesis of (−)cDNA. {#s5}
-------------------------------

The dUTP hypothesis suggests that A-mutagenesis occurs during (+)cDNA synthesis after uracil removal from (−)cDNA by UDG. If correct, then the results in [Fig. 1](#fig01){ref-type="fig"} showing A-mutagenized PCR products in the absence of *VR* sequences would require that mutagenesis occurred during PCR amplification of (−)cDNA templates containing abasic sites, or that error-prone (+)cDNA synthesis had occurred in vivo.

To determine whether abasic sites in template DNA are intrinsically mutagenic during PCR, we generated dU-containing DNA corresponding to the BPP-1 *VR* and flanking sequences using PCR in the presence of dUTP instead of dTTP ([Fig. 5*A*](#fig05){ref-type="fig"}). PCR products were then treated with different amounts of *Escherichia coli* UDG, which removes uracils from both single- and double-stranded DNA substrates. Template DNA treated with 5 U of UDG led to almost no PCR product with Taq and standard dNTPs, whereas decreased amounts of UDG resulted in increased levels of amplification, indicating that abasic sites are inhibitory to PCR ([Fig. 5*B*](#fig05){ref-type="fig"}). No A-mutagenesis was detected in Taq polymerization products derived from dU-DNA treated or untreated with UDG, indicating that abasic sites in the template are not mutagenic during Taq polymerization, or that such templates are refractory to PCR amplification by Taq ([Figs. S4](#d35e326){ref-type="supplementary-material"} and [S5](#d35e326){ref-type="supplementary-material"}).

![A-mutagenesis occurs during (−)cDNA synthesis and does not involve dUTP incorporation. (*A*) dU- and dT-containing DNAs were generated from plasmid pHG∆*ATR,* using Taq-mediated PCR in the presence of either dUTP or dTTP. The products extend from position 99 upstream of *VR* to position 55 downstream of *VR*. The dU-DNA appears to be slightly smaller than the dT-DNA because of the extra methyl group in thymidine. (*B*) UDG treatment of dU-DNA is inhibitory to PCR amplification. dU-DNAs treated with different amounts of UDG were used as templates for PCR with Taq and standard deoxyribonucleotides. The dT-DNA was used as a positive control for PCR. Products from lanes 2 and 5 were cloned for sequence analysis to examine A-mutagenesis ([Figs. S4](#d35e326){ref-type="supplementary-material"} and [S5](#d35e326){ref-type="supplementary-material"}). (*C*) Diagram of the RT-PCR assay (with primer EJ+2 for RT, and primers EJ+4 and TRsp for PCR) to detect covalently linked *TR* RNA-cDNA hybrid molecules. (*D*) Detection of *TR* RNA-cDNA hybrid molecules required both SuperScript III RT and the exogenous primer EJ+2 in the reverse transcription reaction. Sequence analysis of amplified products showed A-mutagenesis ([Fig. S6](#d35e326){ref-type="supplementary-material"}).](pnas.1715952114fig05){#fig05}

To evaluate the possibility that (+)cDNA syntheses can occur in vivo in the absence of *VR* target sequences, we isolated nucleic acids from *Bordetella* cultures transformed with pMX-*td* and performed RT-PCR using primer EJ+2 for reverse transcription and primer pair EJ+4/TRsp for PCR ([Fig. 5 *C* and *D*](#fig05){ref-type="fig"}). A product of the expected size was generated in the complete reaction, but not in the absence of SuperScript III RT, and sequence analysis showed A-mutagenized cDNA products that were covalently linked to the *TR* RNA primer ([Fig. S6](#d35e326){ref-type="supplementary-material"}). Importantly, no RT-PCR products were observed in the absence of sense-strand primer EJ+2 in the RT reaction, showing that (+)cDNA synthesis, which could produce PCR templates in the absence of EJ+2, did not occur in vivo. Thus, our results demonstrate that A-mutagenesis occurs during (−)cDNA synthesis, thereby excluding the dUTP incorporation hypothesis and strongly suggesting that A-mutagenesis is a result of adenine-specific misincorporation by bRT.

Hybrid RNA-cDNA Is Essential for Homing. {#s6}
----------------------------------------

To determine whether hybrid *TR* RNA-cDNA products are required intermediates for homing, we introduced mutations characterized above into donor plasmid pMX-Km1, which encodes a *TR* derivative with the 3′ end of a *Kan*^*R*^ ORF ([@r12]) ([Fig. 6*A*](#fig06){ref-type="fig"}). Mutant constructs, or positive (pMX-Km1) or negative (pMX-Km1/SMAA) controls, were transformed into *Bordetella* lysogen RB50/BPP-1∆*ATR*\**Kan*^*S*^, which contains a 3′ truncated, defective *Kan*^*R*^ gene upstream of (GC)~14~, IMH, and the stem-loop structure ([Fig. 6*A*](#fig06){ref-type="fig"}). DGR homing repairs the defective *Kan*^*R*^ gene, and homing efficiencies were determined as percentages of Kan^R^ colonies. The wild-type plasmid had a homing efficiency of ∼2.2 × 10^−7^, whereas the RT-deficient control had no detectable homing activity (\<6.8 × 10^−11^; [Fig. 6*B*](#fig06){ref-type="fig"}). Mutants *TR*G119A and *sp*C55U, which had reduced cDNA synthesis activities, also had reduced DGR homing (∼1.1 × 10^−9^ and ∼3.5 × 10^−10^, respectively). Complementary mutations *TR*G119A-*sp*C55U partially rescued single-base mutations in DGR homing (∼4.9 × 10^−9^), similar to their effect on cDNA synthesis. No homing activity was observed for mutants *TR*U118C and *sp*A56G, but the complementary mutant *TR*U118C-*sp*A56G regained a low but detectable level of homing activity (∼4.4 × 10^−10^) ([Fig. 6*B*](#fig06){ref-type="fig"}). In a different experiment using a lower kanamycin concentration, we did detect one Kan^R^ colony in mutant *TR*U118C, suggesting a low level of residual activity. Finally, mutant *sp*M4 had no detectable DGR homing, in agreement with cDNA synthesis data. For all constructs with homing activity, sequence analysis showed A-mutagenesis in repaired *Kan*^*R*^ genes. Taken together, we conclude that target-independent cDNA synthesis primed by *sp*A56 in the *TR* RNA intermediate is a key step in DGR mutagenic homing.

![Synthesis of hybrid RNA-cDNA products is required for DGR homing. (*A*) Diagram of the Kan^R^ reporter assay. As the recipient (BPP-1∆*ATR\*Kan*^*S*^ prophage), a defective *Kan*^*R*^ gene, which has a 3′ truncation of six amino acids, was inserted upstream of (GC)~14~, IMH and the stem--loop structure. As the donor (pMX-Km1), a 36-bp *Kan*^*R*^ sequence, which encodes the last 12 amino acids, was inserted upstream of (GC)~14~ and IMH\* in *TR*. DGR homing, or *TR*-to-*VR* transfer, repairs the truncated *Kan*^*R*^ gene, which can be selected based on kanamycin resistance. (*B*) Results of the Kan^R^ reporter assay. Km1 and SMAA were positive and negative controls, respectively. Desired mutations were introduced into plasmid pMX-Km1. Results were the average of three independent experiments, and bars represent mean ± SD. Constructs SMAA, *TR*U118C, *sp*A56G, and *sp*M4 had no detectable homing activity, and bars for these mutants represent the detection limits. \**P* = 0.0019; \*\**P* = 0.0038; \*\*\**P* \< 0.0001; \*\*\*\**P* \< 0.0001 by unpaired Student's *t* test. (*C*) A model for DGR mutagenic homing. Mutagenic homing by the BPP-1 DGR occurs through a *TR* RNA intermediate, which includes *TR* and flanking sequences ([@r6], [@r7]). After transcription, *TR* RNA is cleaved at *sp*A56 in a manner that appears to use bRT as the catalytic component and Avd as a cofactor. Subsequently, the 3′-OH of *sp*A56 is used by bRT as a primer to reverse transcribe the *TR* RNA sequence in an error-prone fashion, resulting in a nascent (−)cDNA copy containing dense substitutions corresponding to adenines in *TR*. The template sequence may then be cleaved by a host activity, and cDNA integration is predicted to involve base pairing interactions between the RNA primer and *VR*, as well as cDNA-*VR* interactions (blue box). We speculate that cleavage of the RNA primer base-paired with *VR* DNA by a host-encoded RNase H-like activity creates what is essentially an "Okazaki fragment." DNA repair by DNA polymerase I would likely include nick-translation, which may remove ∼5--10 bases of DNA in addition to the residual RNA primer, leading to our previous observation of a 3′ marker coconversion boundary (*TR*107-*TR*112) shortly upstream of *TR*117, the first nucleotide copied into cDNA ([@r6]). The nick would then be sealed by a host DNA ligase.](pnas.1715952114fig06){#fig06}

Discussion {#s7}
==========

In this study, we have determined the mechanisms of *TR*-to-*VR* transposition and A-mutagenesis, two key activities of DGR mutagenic homing. Our results show that BPP-1 DGR homing occurs through a target-independent reverse transcription mechanism mediated by an RNP complex consisting of Avd, bRT, and *TR* RNA. After transcription, the *TR* RNA intermediate is cleaved at position *sp*A56 by a mechanism that requires catalytically active bRT ([Fig. 6*C*](#fig06){ref-type="fig"}). This raises the intriguing possibility that bRT itself enzymatically cleaves *TR* RNA at *sp*A56. To our knowledge, no RNase H-less RT, natural or engineered, has ever been shown to have endoribonuclease activity. After *TR* RNA cleavage, bRT uses the 3′-OH of the cleaved RNA as a primer for reverse transcription.

How the cDNA portion of the hybrid *TR* RNA-cDNA intermediate integrates into *VR* remains an unanswered question. Comparing the hybrid RNA-cDNA molecule with *VR* and *TR* DNA sequences, however, may be relevant in this regard. As shown in [Fig. 6*C*](#fig06){ref-type="fig"} (blue box), the RNA primer sequence forms more extensive base pairing interactions with *VR* IMH than with *TR* IMH\*. Our previous observation that IMH dictates the directionality of mutagenic homing is likely explained by cDNA integration at the 3′ end of *VR* resulting from base pairing interactions between the cDNA-linked RNA primer and IMH DNA ([@r1]). The DNA stem--loop structure downstream of *VR*, which increases homing efficiency, could mediate transient DNA unwinding or replication pausing to facilitate strand invasion of the hybrid RNA-cDNA molecule ([@r12]). The RNA primer, once base-paired with *VR* DNA, would likely be cleaved by host-encoded RNase H, leading to formation of an Okazaki-like fragment base-paired with *VR* DNA ([@r17]). Subsequent repair may involve nick-translation catalyzed by DNA polymerase I (or a Pol I-like enzyme), which also has a 5′ → 3′ exonuclease activity that removes nucleotides from RNA-DNA primers during Okazaki fragment maturation. Variability at the 5′ end of the integrated cDNA is consistent with our previous observation of a marker coconversion boundary spanning several nucleotides (*TR*107-*TR*112) shortly upstream of *TR*117, the first residue reverse transcribed ([@r6]). Eventually, nicks would be connected by host DNA ligase.

A-mutagenesis is perhaps the most distinctive feature of DGRs and is considered to be an intrinsic property of DGR-encoded RTs ([@r2]). Our results clearly show that A-mutagenesis occurs during (−)cDNA synthesis, which precludes models that invoke dUTP incorporation and UDG-mediated base removal followed by DNA replication. In support of this, Taq does not insert random nucleotides when amplifying DNA templates containing abasic sites, and there is no detectable (+)cDNA synthesis in vivo in the absence of *VR*. Thus, our results provide convincing evidence that A-mutagenesis does not involve dUTP incorporation, indicating it is a consequence of DGR RT-mediated incorporation of random nucleotides. To our knowledge, DGR RTs are the most error-prone RTs ever discovered. The error rate of the BPP-1 RT, which stands at ∼40% for *TR* adenine residues, is more than 13,000 times higher than that of the HIV type 1 (HIV-1) RT, which misincorporates nucleotides at a rate of ∼1.4--3.0 × 10^−5^ per cycle per base ([@r18], [@r19]). The low fidelity of HIV-1 replication plays a critical role in virus immune evasion and drug resistance. DGR RTs are related to HIV-1 RT and have conserved finger and palm domains ([@r2]). It will be of interest to determine whether the unique residues and motifs conserved within the DGR RT clade play a role in determining A-specific infidelity during polymerization. We predict that the fundamental mechanism of mutagenic homing will be conserved among the thousands of DGRs identified in bacteria, archaea, and their viruses, as they are structurally similar and have related RTs and signatures of A-mutagenesis ([@r4]). A better understanding of DGR mutagenic homing will be important for understanding their physiological roles in host organisms, and for exploiting DGRs for diverse bioengineering applications.

Materials and Methods {#s8}
=====================

Bacterial Strains, DNA Oligonucleotides, and Plasmid Constructs. {#s9}
----------------------------------------------------------------

*B. bronchiseptica* strains RB50 and RB50/BPP-1∆*ATR*\**Kan*^*S*^ lysogen have been described ([@r12], [@r20]). *E. coli* DH5αλpir was used for routine cloning ([@r21]). DNA oligonucleotides are listed in [Table S1](#d35e326){ref-type="supplementary-material"}. Plasmid constructs are described in [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"}.

PCR Assay of *VR*-Independent cDNA Synthesis. {#s10}
---------------------------------------------

Plasmids pMX-E1E2, pMX-*td* and derivatives of pMX-*td* were electroporated into *Bordetella* RB50 cells. Transformed cells were then cultured and used for *VR*-independent cDNA synthesis assay as described in [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"}.

cDNA Primer Determination by 5′ RACE. {#s11}
-------------------------------------

Nucleic acids were isolated from *Bordetella* RB50 cells transformed with either plasmid pMX-*td* or pMX-*td*/SMAA. 5′ RACE assay was performed as described in [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"}.

RT-PCR Assay of *VR*-Independent cDNA Synthesis. {#s12}
------------------------------------------------

Plasmid pMX-*td* and its derivatives were electroporated into *Bordetella* RB50 cells. Nucleic acids were then isolated, and *VR*-independent cDNA synthesis assay was performed as described in [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"}.

RNase Protection Assay. {#s13}
-----------------------

RNase protection assay was performed using the RPA III kit (Ambion) according to manufacturer's instructions (see [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"} for details).

Primer Extension and Splint Ligation Assays. {#s14}
--------------------------------------------

To determine whether *TR* RNA is cleaved, primer extension and splint ligation assays were performed as described in [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"}. To check whether cDNA is branched at *sp*A56, a similar primer extension assay was performed with ^32^P-labeled primer P3, which anneals to (−)cDNA.

Fidelity of Taq in Copying Abasic Sites. {#s15}
----------------------------------------

Deoxyuracil (dU) residues were introduced into BPP-1 *VR* and its flanking sequences by PCR in the presence of dUTP. The dU-containing DNA was then treated with UDG to generate DNA containing abasic sites (see [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"} for more details). Subsequently, UDG-treated DNA samples were used as templates to determine the fidelity of Taq polymerase in copying abasic sites (see [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"} for more details).

Kan^R^ Reporter Assay. {#s16}
----------------------

The *Kan*^*R*^-based DGR homing assay was performed as described previously, with minor modifications (see [*SI Materials and Methods*](#d35e326){ref-type="supplementary-material"} for more details) ([@r12]).
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